266
Views
22
CrossRef citations to date
0
Altmetric
Articles

Linking physiological parameters to perturbations in the human exposome: Environmental exposures modify blood pressure and lung function via inflammatory cytokine pathway

, , , &

References

  • Alexis, N. E., Zhou, H., Lay, J. C., Harris, B., Hernandez, M. L., Lu, T. S., Bromberg, P. A., Diaz-Sanchez, D., Devlin, R. B., Kleeberger, S. R., and Peden, D. B. 2009. The glutathione-S-transferase Mu 1 null genotype modulates ozone-induced airway inflammation in human subjects. J. Allergy Clin. Immunol. 124: 1222–1228.
  • Angrish, M. M., Madden, M. C., and Pleil, J. D. 2015. Probe molecule (PrM) approach in adverse outcome pathway (AOP) based high-throughput screening (HTS): In vivo discovery for developing in vitro target methods. Chem. Res. Toxicol. 28: 551–559.
  • Angrish, M. M., Pleil, J. D., Stiegel, M. A., Madden, M. C., Moser, V. C., and Herr, D. W. 2016. Taxonomic applicability of inflammatory cytokines in adverse outcome pathway (AOP) development. J. Toxicol. Environ. Health A 79: 184–196.
  • Athersuch, T. J. 2012. The role of metabolomics in characterizing the human exposome. Bioanalysis 4: 2207–2212.
  • Barath, S., Langrish, J. P., Lundback, M., Bosson, J. A., Goudie, C., Newby, D. E., Sandstrom, T., Mills, N. L., and Blomberg, A. 2013. Short-term exposure to ozone does not impair vascular function or affect heart rate variability in healthy young men. Toxicol. Sci. 135: 292–299.
  • Barker, J. S., Wu, Z., Hunter, D. D., and Dey, R. D. 2015. Ozone exposure initiates a sequential signaling cascade in airways involving interleukin-1beta release, nerve growth factor secretion, and substance P upregulation. J. Toxicol. Environ. Health A 78: 397–407.
  • Bautista, L. E., Vera, L. M., Arenas, I. A., and Gamarra, G. 2005. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J. Hum. Hypertens. 19: 149–154.
  • Bergamaschi, E., De Palma, G., Mozzoni, P., Vanni, S., Vettori, M. V., Broeckaert, F., Bernard, A., and Mutti, A. 2001. Polymorphism of quinone-metabolizing enzymes and susceptibility to ozone-induced acute effects. Am. J. Respir. Crit. Care. Med. 163: 1426–1431.
  • Bhagat, K. and Vallance, P. 1997. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 96: 3042–3047.
  • Boshuizen, M., Leopold, J. H., Zakharkina, T., Knobel, H. H., Weda, H., Nijsen, T. M., Vink, T. J., Sterk, P. J., Schultz, M. J., Bos, L. D., and Consortium, M. 2015. Levels of cytokines in broncho-alveolar lavage fluid, but not in plasma, are associated with levels of markers of lipid peroxidation in breath of ventilated ICU patients. J. Breath Res. 9: 036010.
  • Brook, R. D., Bard, R. L., Morishita, M., Dvonch, J. T., Wang, L., Yang, H. Y., Spino, C., Mukherjee, B., Kaplan, M. J., Yalavarthi, S., Oral, E. A., Ajluni, N., Sun, Q., Brook, J. R., Harkema, J., and Rajagopalan, S. 2014. Hemodynamic, autonomic, and vascular effects of exposure to coarse particulate matter air pollution from a rural location. Environ. Health Persp. 122: 624–630.
  • Brook, R. D., Urch, B., Dvonch, J. T., Bard, R. L., Speck, M., Keeler, G., Morishita, M., Marsik, F. J., Kamal, A. S., Kaciroti, N., Harkema, J., Corey, P., Silverman, F., Gold, D. R., Wellenius, G., Mittleman, M. A., Rajagopalan, S., and Brook, J. R. 2009. Insights into the mechanisms and mediators of the effects of air pollution exposure on blood pressure and vascular function in healthy humans. Hypertension. 54: 659–667.
  • Chae, C. U., Lee, R. T., Rifai, N., and Ridker, P. M. 2001. Blood pressure and inflammation in apparently healthy men. Hypertension. 38: 399–403.
  • Chaturvedi, S., Siegel, D., Wagner, C. L., Park, J., Van De Velde, H., Vermeulen, J., Fung, M. C., Reddy, M., Hall, B., and Sasser, K. 2015. Development and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin-6. Br. J. Clin. Pharmacol. 80: 687–697.
  • Chung, K. F. and Barnes, P. J. 1999. Cytokines in asthma. Thorax 54: 825–857.
  • Costa, S., Ferreira, J., Silveira, C., Costa, C., Lopes, D., Relvas, H., Borrego, C., Roebeling, P., Miranda, A. I., and Paulo Teixeira, J. 2014. Integrating health on air quality assessment—review report on health risks of two major European outdoor air pollutants: PM and NO2. J. Toxicol. Environ. Health B 17: 307–340.
  • De Oliveira, B. F. A., Chacra, A. P. M., Frauches, T. S., Vallochi, A., and Hacon, S. 2014. A curated review of recent literature of biomarkers used for assessing air pollution exposures and effects in humans. J. Toxicol. Environ. Health B 17: 369–410.
  • Devlin, R. B., Duncan, K. E., Jardim, M., Schmitt, M. T., Rappold, A. G., and Diaz-Sanchez, D. 2012. Controlled exposure of healthy young volunteers to ozone causes cardiovascular effects. Circulation 126: 104–111.
  • Dix, D. J., Houck, K. A., Martin, M. T., Richard, A. M., Setzer, R. W., and Kavlock, R. J. 2007. The ToxCast program for prioritizing toxicity testing of environmental chemicals. Toxicol. Sci. 95: 5–12.
  • Dong, G. H., Qian, Z. M., Xaverius, P. K., Trevathan, E., Maalouf, S., Parker, J., Yang, L., Liu, M. M., Wang, D., Ren, W. H., Ma, W., Wang, J., Zelicoff, A., Fu, Q., and Simckes, M. 2013. Association between long-term air pollution and increased blood pressure and hypertension in China. Hypertension 61: 578–584.
  • Edwards, S. W., Tan, Y. M., Villeneuve, D. L., Meek, M. E., and McQueen, C. A. 2016. Adverse outcome pathways-organizing toxicological information to improve decision making. J. Pharmacol. Exp. Ther. 356: 170–181.
  • Fariss, M. W., Gilmour, M. I., Reilly, C. A., Liedtke, W., and Ghio, A. J. 2013. Emerging mechanistic targets in lung injury induced by combustion-generated particles. Toxicol. Sci. 132: 253–267.
  • Feghali, C. A. and Wright, T. M. 1997. Cytokines in acute and chronic inflammation. Front. Biosci. 2: d12–d26.
  • Ghanem, F. A. and Movahed, A. 2007. Inflammation in high blood pressure: A clinician perspective. J. Am. Soc. Hypertens. 1: 113–119.
  • Gilliland, F. D., Li, Y. F., Saxon, A., and Diaz-Sanchez, D. 2004. Effect of glutathione-S-transferase M1 and P1 genotypes on xenobiotic enhancement of allergic responses: Randomised, placebo-controlled crossover study. Lancet 363: 119–125.
  • Groh, K. J. and Tollefsen, K. E. 2015. The Challenge: Adverse outcome pathways in research and regulation–Current status and future perspectives. Environ. Toxicol. Chem. 34: 1935.
  • Hazucha, M. J., Madden, M., Pape, G., Becker, S., Devlin, R., Koren, H. S., Kehrl, H., and Bromberg, P. A. 1996. Effects of cyclo-oxygenase inhibition on ozone-induced respiratory inflammation and lung function changes. Eur. J. Appl. Physiol. Occup. Physiol. 73: 17–27.
  • Hoffmann, B., Luttmann-Gibson, H., Cohen, A., Zanobetti, A., De Souza, C., Foley, C., Suh, H. H., Coull, B. A., Schwartz, J., Mittleman, M., and Stone, P. 2012. Opposing effects of particle pollution, ozone, and ambient temperature on arterial blood pressure. Environ. Health. Persp. 120: 241–246.
  • Holgate, S. T., Sandstrom, T., Frew, A. J., Stenfors, N., Nordenhall, C., Salvi, S., Blomberg, A., Helleday, R., and Soderberg, M. 2003. Health effects of acute exposure to air pollution. Part I: Healthy and asthmatic subjects exposed to diesel exhaust. Res. Rep. Health Eff. Inst. 1-30(discussion): 51–67.
  • Hunt, J. 2002. Exhaled breath condensate: An evolving tool for noninvasive evaluation of lung disease. J. Allergy. Clin. Immunol. 110: 28–34.
  • Kasthurinaidu, S. P., Ramasamy, T., Ayyavoo, J., Dave, D. K., and Adroja, D. A. 2015. GST M1-T1 null allele frequency patterns in geographically assorted human populations: A phylogenetic approach. Plos One 10: e0118660.
  • Kim, C. S., Alexis, N. E., Rappold, A. G., Kehrl, H., Hazucha, M. J., Lay, J. C., Schmitt, M. T., Case, M., Devlin, R. B., Peden, D. B., and Diaz-Sanchez, D. 2011. Lung function and inflammatory responses in healthy young adults exposed to 0.06 ppm ozone for 6.6 hours. Am. J. Respir. Crit. Care Med. 183: 1215–1221.
  • Lioy, P. J. and Rappaport, S. M. 2011. Exposure science and the exposome: an opportunity for coherence in the environmental health science. Environ. Health. Persp. 119: A466-A467.
  • Madden, M. C., Hanley, N., Harder, S., Velez, G., and Raymer, J. 1997. Increased amounts of hydrogen peroxide in the breath of subjects exposed to ozone. Inhal. Toxicol. 9: 317–330.
  • Madden, M. C., Stevens, T., Case, M., Schmitt, M., Diaz-Sanchez, D., Bassett, M., Montilla, T. S., Berntsen, J., and Devlin, R. B. 2014. Diesel exhaust modulates ozone-induced lung function decrements in healthy human volunteers. Part. Fibre. Toxicol. 11: 37.
  • Margretardottir, O. B., Thorleifsson, S. J., Gudmundsson, G., Olafsson, I., Benediktsdottir, B., Janson, C., Buist, A. S., and Gislason, T. 2009. Hypertension, systemic inflammation and body weight in relation to lung function impairment-an epidemiological study. Copd. 6: 250–255.
  • Mirhafez, S. R., Mohebati, M., Feiz Disfani, M., Saberi Karimian, M., Ebrahimi, M., Avan, A., Eslami, S., Pasdar, A., Rooki, H., Esmaeili, H., Ferns, G. A., and Ghayour-Mobarhan, M. 2014. An imbalance in serum concentrations of inflammatory and anti-inflammatory cytokines in hypertension. J. Am. Soc. Hypertens. 8: 614–623.
  • Moldoveanu, B., Otmishi, P., Jani, P., Walker, J., Sarmiento, X., Guardiola, J., Saad, M., and Yu, J. 2009. Inflammatory mechanisms in the lung. J. Inflamm. Res. 2: 1–11.
  • Montuschi, P. 2007. Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Ther. Adv. Respir. Dis. 1: 5–23.
  • Morishita, M., Bard, R. L., Wang, L., Das, R., Dvonch, J. T., Spino, C., Mukherjee, B., Sun, Q., Harkema, J. R., Rajagopalan, S., and Brook, R. D. 2015. The characteristics of coarse particulate matter air pollution associated with alterations in blood pressure and heart rate during controlled exposures. J. Expo. Sci. Environ. Epidemiol. 25: 153–159.
  • Pleil, J. D. 2012a. Categorizing biomarkers of the human exposome and developing metrics for assessing environmental sustainability. J. Toxicol. Environ. Health B. 15: 264–280.
  • Pleil, J. D. 2016a. QQ-plots for assessing distributions of biomarker measurements and generating defensible summary statistics. J. Breath Res. 10: 035001.
  • Pleil, J. D. 2016b. Breath biomarkers in toxicology. Arch. Toxicol. 90: 2669–2682.
  • Pleil, J. D. 2016c. Cellular respiration: Replicating in vivo systems biology for in vitro exploration of human exposome, microbiome, and disease pathogenesis biomarkers. J. Breath Res. 10: 010201.
  • Pleil, J. D., Angrish, M. M., and Madden, M. C. 2015a. Immunochemistry for high-throughput screening of human exhaled breath condensate (EBC) media: Implementation of automated Quanterix SIMOA instrumentation. J. Breath Res. 9: 047108.
  • Pleil, J. D., Beauchamp, J. D., Miekisch, W., and Funk, W. E. 2015b. Adapting biomarker technologies to adverse outcome pathways (AOPs) research: current thoughts on using in vivo discovery for developing in vitro target methods. J. Breath Res. 9: 039001.
  • Pleil, J. D. and Sobus, J. R. 2016. Estimating central tendency from a single spot measure: A closed-form solution for lognormally distributed biomarker data for risk assessment at the individual level. J. Toxicol. Environ. Health A 79: 837–847.
  • Pleil, J. D. and Stiegel, M. A. 2013. Evolution of environmental exposure science: Using breath-borne biomarkers for “discovery” of the human exposome. Anal. Chem. 85: 9984–9990.
  • Pleil, J. D., Williams, M. A., and Sobus, J. R. 2012b. Chemical Safety for Sustainability (CSS): Human in vivo biomonitoring data for complementing results from in vitro toxicology–a commentary. Toxicol. Lett. 215: 201–207.
  • Rappaport, S. M., Barupal, D. K., Wishart, D., Vineis, P., and Scalbert, A. 2014. The blood exposome and its role in discovering causes of disease. Environ. Health Persp. 122: 769–774.
  • Rappaport, S. M. and Kupper, L. L. 2008. Quant. Expos Asse. El Cerrito, Cali.: S.M. Rappaport.
  • Rappaport, S. M. and Smith, M. T. 2010. Epidemiology. Environment and disease risks. Science 330: 460–461.
  • Richard, A. M., Judson, R. S., Houck, K. A., Grulke, C. M., Volarath, P., Thillainadarajah, I., Yang, C., Rathman, J., Martin, M. T., Wambaugh, J. F., Knudsen, T. B., Kancherla, J., Mansouri, K., Patlewicz, G., Williams, A. J., Little, S. B., Crofton, K. M., and Thomas, R. S. 2016. ToxCast chemical landscape: Paving the road to 21st Century toxicology. Chem. Res. Toxicol. 29: 1225–1251.
  • Saito, Y., Azuma, A., Kudo, S., Takizawa, H., and Sugawara, I. 2002. Effects of diesel exhaust on murine alveolar macrophages and a macrophage cell line. Exp. Lung. Res. 28: 201–217.
  • Sawyer, K., Mundandhara, S., Ghio, A. J., and Madden, M. C. 2010. The effects of ambient particulate matter on human alveolar macrophage oxidative and inflammatory responses. J. Toxicol. Environ. Health A 73: 41–57.
  • Schnabel, E., Nowak, D., Brasche, S., Wichmann, H. E., and Heinrich, J. 2011. Association between lung function, hypertension and blood pressure medication. Respir. Med. 105: 727–733.
  • Shah, F. and Greene, N. 2014. Analysis of Pfizer compounds in EPA’s ToxCast chemicals-assay space. Chem. Res. Toxicol. 27: 86–98.
  • Shan, M., Yang, X., Ezzati, M., Chaturvedi, N., Coady, E., Hughes, A., Shi, Y., Yang, M., Zhang, Y., and Baumgartner, J. 2014. A feasibility study of the association of exposure to biomass smoke with vascular function, inflammation, and cellular aging. Environ. Res. 135: 165–172.
  • Silva, M., Pham, N., Lewis, C., Iyer, S., Kwok, E., Solomon, G., and Zeise, L. 2015. A Comparison of ToxCast test results with in vivo and other in vitro endpoints for neuro, endocrine, and developmental toxicities: A case study using endosulfan and methidathion. Birth Defects Res. B Dev. Reprod. Toxicol. 104: 71–89.
  • Stevens, T., Case, M., Rappold, A., Pleil, J. D., Diaz-Sanchez, D., Cascio, W., Devlin, R., and Madden, M. 2014. Cardiovascular effects of diesel exhaust and ozone in a multi-pollutant context. Toxicologist 138(1): 227. 876d (Abstract).
  • Stiegel, M. A., Pleil, J. D., Sobus, J. R., and Madden, M. C. 2016. Inflammatory cytokines and white blood cell counts response to environmental levels of diesel exhaust and ozone inhalation exposures. Plos One 11: e0152458.
  • Tan, Y. M., Sobus, J., Chang, D., Tornero-Velez, R., Goldsmith, M., Pleil, J., and Dary, C. 2012. Reconstructing human exposures using biomarkers and other “clues.” J. Toxicol. Environ. Health B 15: 22–38.
  • Tank, J., Biller, H., Heusser, K., Holz, O., Diedrich, A., Framke, T., Koch, A., Grosshennig, A., Koch, W., Krug, N., Jordan, J., and Hohlfeld, J. M. 2011. Effect of acute ozone induced airway inflammation on human sympathetic nerve traffic: A randomized, placebo controlled, crossover study. Plos One 6: e18737.
  • Thomas, R. S., Black, M. B., Li, L., Healy, E., Chu, T. M., Bao, W., Andersen, M. E., and Wolfinger, R. D. 2012. A comprehensive statistical analysis of predicting in vivo hazard using high-throughput in vitro screening. Toxicol. Sci. 128: 398–417.
  • Tornqvist, H., Mills, N. L., Gonzalez, M., Miller, M. R., Robinson, S. D., Megson, I. L., Macnee, W., Donaldson, K., Soderberg, S., Newby, D. E., Sandstrom, T., and Blomberg, A. 2007. Persistent endothelial dysfunction in humans after diesel exhaust inhalation. Am. J. Respir. Crit. Care Med. 176: 395–400.
  • Turner, M. D., Nedjai, B., Hurst, T., and Pennington, D. J. 2014. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochim. Biophys. Acta. 1843: 2563–2582.
  • Van Eeden, S. F., Tan, W. C., Suwa, T., Mukae, H., Terashima, T., Fujii, T., Qui, D., Vincent, R., and Hogg, J. C. 2001. Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM(10)). Am. J. Respir. Crit. Care Med. 164: 826–830.
  • Vaschetto, R., Corradi, M., Goldoni, M., Cancelliere, L., Pulvirenti, S., Fazzini, U., Capuzzi, F., Longhini, F., Mutti, A., Della Corte, F., and Navalesi, P. 2015. Sampling and analyzing alveolar exhaled breath condensate in mechanically ventilated patients: A feasibility study. J. Breath Res. 9: 047106.
  • Vinken, M. 2013. The adverse outcome pathway concept: A pragmatic tool in toxicology. Toxicology 312: 158–165.
  • Wallace, M. A., Kormos, T. M., and Pleil, J. D. 2016. Blood-borne biomarkers and bioindicators for linking exposure to health effects in environmental health science. J. Toxicol. Environ. Health B 19: 380–409.
  • Wetmore, B. A., Wambaugh, J. F., Ferguson, S. S., Sochaski, M. A., Rotroff, D. M., Freeman, K., Clewell, H. J., 3rd, Dix, D. J., Andersen, M. E., Houck, K. A., Allen, B., Judson, R. S., Singh, R., Kavlock, R. J., Richard, A. M., and Thomas, R. S. 2012. Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment. Toxicol. Sci. 125: 157–174.
  • Wild, C. P. 2005. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol. Biomarkers Prev. 14: 1847–1850.
  • Williams, J. and Pleil, J. 2016. Crowd-based breath analysis: Assessing behavior, activity, exposures, and emotional response of people in groups. J. Breath Res. 10: 032001.
  • Wu, Y., Vollmer, W. M., Buist, A. S., Tsai, R., Cen, R., Wu, X., Chen, P., Li, Y., Guo, C., Mai, J., and Davis, C. E. 1998. Relationship between lung function and blood pressure in Chinese men and women of Beijing and Guangzhou. PRC-USA Cardiovascular and Cardiopulmonary Epidemiology Research Group. Int. J. Epidemiol. 27: 49–56.
  • Xu, Y., Barregard, L., Nielsen, J., Gudmundsson, A., Wierzbicka, A., Axmon, A., Jonsson, B. A., Karedal, M., and Albin, M. 2013. Effects of diesel exposure on lung function and inflammation biomarkers from airway and peripheral blood of healthy volunteers in a chamber study. Part. Fibre. Toxicol. 10: 60.
  • Yang, I. A., Fong, K. M., Zimmerman, P. V., Holgate, S. T., and Holloway, J. W. 2008. Genetic susceptibility to the respiratory effects of air pollution. Thorax 63: 555–563.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.